1.
Querfeld C, Kuzel T, Guitart J, Rosen S. Lenalidomide (Revlimid®) in patients with cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 11 [cited 2024 May 6];3(1). Available from: https://www.pagepress.org/journals/hmr/article/view/546